Project Grant HT94252410108
Award Date
3/1/24
Completion Date
2/28/26
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
The University of California, Los Angeles (UCLA) was awarded a $1,181,251 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from April 15, 2025 to April 14, 2028, will support UCLA's research on developing neuronal exosome-based biomarkers for the diagnosis and disease progression monitoring of amyotrophic lateral sclerosis (ALS). This federal grant award...
The Department of the Army Medical Command, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,210,500 project grant to Mayo Clinic to explore novel biomarkers for amyotrophic lateral sclerosis (ALS) using a multiomics approach. The 3-year project (Apr 2025 - Mar 2028) will utilize immunoprofiling, extracellular vesicle analysis, and TDP-43 aggregation assays to identify potential diagnostic and prognostic markers for ALS. Mayo Clinic, a renowned non-profit...
This federal Project Grant award, valued at $1,103,084.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports the development of a personalized blood-based diagnostic assay for early detection of Amyotrophic Lateral Sclerosis (ALS) at Arizona State University. The university will collaborate with a sub-awardee, Georgetown University, to conduct the research. The project aims to transform healthcare for...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This federal Project Grant award of $1,117,328.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on proteomic biomarkers for amyotrophic lateral sclerosis (ALS) disease prognosis and progression monitoring. The award recipient, The University of Queensland in Australia, will conduct this research project from April 1, 2025, through March 31, 2027. The project aims to develop innovative...
The University of California, San Diego received a $694,650 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award will support research on RNA-directed therapy for amyotrophic lateral sclerosis (ALS) linked to the C9ORF72 gene using engineered zinc finger nucleases. The Military Medical Research and Development program aims to transform military and public health through...
The University of Massachusetts Medical School was awarded a $1,005,000 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to develop pad inhibitors for the treatment of amyotrophic lateral sclerosis (ALS). The award, which commenced on September 30, 2024, will support research activities through September 29, 2026. The Medical School's Grants and Contracts Administration division, doing business as UMms, will lead the project...
This federal Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), provides $963,000.00 to The Regents of the University of California, doing business as University of California, Berkeley, to conduct research on "REBALANCING C9ORF72 LOSS OF FUNCTION IN AMYOTROPHIC LATERAL SCLEROSIS". The research, which will take place over a two-year period from March 1, 2024 to February 28, 2026, aims to...
The University of California, San Diego will receive $790,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The university will conduct research on neuron-targeted caveolin gene therapy as a potential route of administration to treat amyotrophic lateral sclerosis. Specifically, the funding will...
The University of California, Los Angeles (UCLA) was awarded a $418,357 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCLA's efforts to enhance delivery of adeno-associated virus (AAV)-CRISPR to muscle stem cells from September 30, 2022 to September 29, 2024. As the sub-awardee, UCLA will leverage the funding to conduct research that aims to transform military and...